Stocks · Health care · Biological Products, (No Diagnostic Substances)

Acumen Pharmaceuticals, Inc.

ABOS Clue Score27
United States Fiscal year ends December CIK 0001576885 Results filed 26 Oct 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Matt Zuga
23 Jan 2025
CFO & Chief Business Officer
Sold on a plan
28,902
$1.72
$49.63K
Eric Siemers
21 Jan 2025
Chief Medical Officer
Sold on a plan
3,219
$1.59
$5.12K
Russell Barton
21 Jan 2025
Chief Operating Officer
Sold on a plan
2,914
$1.61
$4.69K
Derek M Meisner
21 Jan 2025
Chief Legal Officer & Corp Sec
Sold on a plan
3,418
$1.59
$5.43K
Daniel Joseph OConnell
21 Jan 2025
Chief Executive Officer
Sold on a plan
12,619
$1.59
$20.10K
Matt Zuga
21 Jan 2025
CFO & Chief Business Officer
Sold on a plan
4,364
$1.60
$6.99K
Eric Siemers
3 Jan 2025
Chief Medical Officer
Sold on a plan
10,859
$1.85
$20.05K
Matt Zuga
3 Jan 2025
CFO & Chief Business Officer
Sold on a plan
13,235
$1.84
$24.37K
Russell Barton
3 Jan 2025
Chief Operating Officer
Sold on a plan
7,636
$1.86
$14.23K
Derek M Meisner
3 Jan 2025
Chief Legal Officer & Corp Sec
Sold on a plan
11,122
$1.84
$20.51K
Daniel Joseph OConnell
3 Jan 2025
Chief Executive Officer
Sold on a plan
47,778
$1.84
$87.87K
Derek M Meisner
19 Jan 2024
Chief Legal Officer & Corp Sec
Sold on a plan
8,933
$3.48
$31.05K
Daniel Joseph OConnell
19 Jan 2024
President and CEO
Sold on a plan
15,200
$3.47
$52.75K
Russell Barton
18 Jan 2024
Chief Operating Officer
Sold on a plan
2,833
$3.73
$10.56K
Eric Siemers
18 Jan 2024
Chief Medical Officer
Sold on a plan
3,124
$3.71
$11.60K
Matt Zuga
18 Jan 2024
CFO & Chief Business Officer
Sold on a plan
4,242
$3.71
$15.72K

What was left out

Form 4 filings counted 120
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 9
Sales on a Rule 10b5-1 plan 16
Sales straight out of an exercise 8
Sales at will 42
Transactions with no price 0
Shares from compensation/vesting 30,618,063
History held since 2 Jul 2021